nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0968	0.178	CbGbCtD
Fenofibrate—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0903	0.166	CbGbCtD
Fenofibrate—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0734	0.135	CbGbCtD
Fenofibrate—CYP2C9—Dexamethasone—ankylosing spondylitis	0.063	0.116	CbGbCtD
Fenofibrate—CYP3A4—Betamethasone—ankylosing spondylitis	0.0629	0.116	CbGbCtD
Fenofibrate—CYP3A4—Prednisolone—ankylosing spondylitis	0.0621	0.114	CbGbCtD
Fenofibrate—CYP3A4—Prednisone—ankylosing spondylitis	0.0586	0.108	CbGbCtD
Fenofibrate—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0366	0.0673	CbGbCtD
Fenofibrate—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000616	0.00135	CcSEcCtD
Fenofibrate—Myalgia—Triamcinolone—ankylosing spondylitis	0.000611	0.00134	CcSEcCtD
Fenofibrate—Pneumonia—Methotrexate—ankylosing spondylitis	0.00061	0.00134	CcSEcCtD
Fenofibrate—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000609	0.00134	CcSEcCtD
Fenofibrate—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000609	0.00134	CcSEcCtD
Fenofibrate—Eye disorder—Prednisone—ankylosing spondylitis	0.000609	0.00133	CcSEcCtD
Fenofibrate—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000607	0.00133	CcSEcCtD
Fenofibrate—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000606	0.00133	CcSEcCtD
Fenofibrate—Infestation—Methotrexate—ankylosing spondylitis	0.000606	0.00133	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000605	0.00133	CcSEcCtD
Fenofibrate—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000604	0.00132	CcSEcCtD
Fenofibrate—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000604	0.00132	CcSEcCtD
Fenofibrate—Discomfort—Triamcinolone—ankylosing spondylitis	0.000603	0.00132	CcSEcCtD
Fenofibrate—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000602	0.00132	CcSEcCtD
Fenofibrate—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000597	0.00131	CcSEcCtD
Fenofibrate—Renal failure—Methotrexate—ankylosing spondylitis	0.000596	0.00131	CcSEcCtD
Fenofibrate—Angiopathy—Prednisone—ankylosing spondylitis	0.000591	0.00129	CcSEcCtD
Fenofibrate—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000589	0.00129	CcSEcCtD
Fenofibrate—Malaise—Dexamethasone—ankylosing spondylitis	0.000587	0.00129	CcSEcCtD
Fenofibrate—Malaise—Betamethasone—ankylosing spondylitis	0.000587	0.00129	CcSEcCtD
Fenofibrate—Oedema—Triamcinolone—ankylosing spondylitis	0.000586	0.00128	CcSEcCtD
Fenofibrate—Vertigo—Dexamethasone—ankylosing spondylitis	0.000585	0.00128	CcSEcCtD
Fenofibrate—Vertigo—Betamethasone—ankylosing spondylitis	0.000585	0.00128	CcSEcCtD
Fenofibrate—Arrhythmia—Prednisone—ankylosing spondylitis	0.000582	0.00127	CcSEcCtD
Fenofibrate—Infection—Triamcinolone—ankylosing spondylitis	0.000582	0.00127	CcSEcCtD
Fenofibrate—Sweating—Methotrexate—ankylosing spondylitis	0.000581	0.00127	CcSEcCtD
Fenofibrate—Infection—Methylprednisolone—ankylosing spondylitis	0.00058	0.00127	CcSEcCtD
Fenofibrate—Insomnia—Prednisolone—ankylosing spondylitis	0.000576	0.00126	CcSEcCtD
Fenofibrate—Alopecia—Prednisone—ankylosing spondylitis	0.000575	0.00126	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000573	0.00126	CcSEcCtD
Fenofibrate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000573	0.00126	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000572	0.00125	CcSEcCtD
Fenofibrate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000571	0.00125	CcSEcCtD
Fenofibrate—Mental disorder—Prednisone—ankylosing spondylitis	0.000571	0.00125	CcSEcCtD
Fenofibrate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00057	0.00125	CcSEcCtD
Fenofibrate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000567	0.00124	CcSEcCtD
Fenofibrate—Malnutrition—Prednisone—ankylosing spondylitis	0.000567	0.00124	CcSEcCtD
Fenofibrate—Erythema—Prednisone—ankylosing spondylitis	0.000567	0.00124	CcSEcCtD
Fenofibrate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000566	0.00124	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000565	0.00124	CcSEcCtD
Fenofibrate—Hypertension—Betamethasone—ankylosing spondylitis	0.000562	0.00123	CcSEcCtD
Fenofibrate—Hypertension—Dexamethasone—ankylosing spondylitis	0.000562	0.00123	CcSEcCtD
Fenofibrate—Myalgia—Dexamethasone—ankylosing spondylitis	0.000554	0.00121	CcSEcCtD
Fenofibrate—Myalgia—Betamethasone—ankylosing spondylitis	0.000554	0.00121	CcSEcCtD
Fenofibrate—Anxiety—Dexamethasone—ankylosing spondylitis	0.000552	0.00121	CcSEcCtD
Fenofibrate—Anxiety—Betamethasone—ankylosing spondylitis	0.000552	0.00121	CcSEcCtD
Fenofibrate—Discomfort—Dexamethasone—ankylosing spondylitis	0.000548	0.0012	CcSEcCtD
Fenofibrate—Discomfort—Betamethasone—ankylosing spondylitis	0.000548	0.0012	CcSEcCtD
Fenofibrate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000546	0.0012	CcSEcCtD
Fenofibrate—Pain—Prednisolone—ankylosing spondylitis	0.000544	0.00119	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—ankylosing spondylitis	0.000544	0.00119	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00054	0.00118	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000533	0.00117	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000532	0.00117	CcSEcCtD
Fenofibrate—Oedema—Betamethasone—ankylosing spondylitis	0.000531	0.00116	CcSEcCtD
Fenofibrate—Oedema—Dexamethasone—ankylosing spondylitis	0.000531	0.00116	CcSEcCtD
Fenofibrate—Insomnia—Triamcinolone—ankylosing spondylitis	0.00053	0.00116	CcSEcCtD
Fenofibrate—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000528	0.00116	CcSEcCtD
Fenofibrate—Infection—Betamethasone—ankylosing spondylitis	0.000528	0.00116	CcSEcCtD
Fenofibrate—Infection—Dexamethasone—ankylosing spondylitis	0.000528	0.00116	CcSEcCtD
Fenofibrate—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000526	0.00115	CcSEcCtD
Fenofibrate—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000526	0.00115	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000525	0.00115	CcSEcCtD
Fenofibrate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000525	0.00115	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—ankylosing spondylitis	0.000525	0.00115	CcSEcCtD
Fenofibrate—Anaemia—Prednisone—ankylosing spondylitis	0.000524	0.00115	CcSEcCtD
Fenofibrate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000522	0.00114	CcSEcCtD
Fenofibrate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000521	0.00114	CcSEcCtD
Fenofibrate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000521	0.00114	CcSEcCtD
Fenofibrate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00052	0.00114	CcSEcCtD
Fenofibrate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00052	0.00114	CcSEcCtD
Fenofibrate—Tachycardia—Betamethasone—ankylosing spondylitis	0.000519	0.00114	CcSEcCtD
Fenofibrate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000519	0.00114	CcSEcCtD
Fenofibrate—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000515	0.00113	CcSEcCtD
Fenofibrate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000514	0.00113	CcSEcCtD
Fenofibrate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000514	0.00113	CcSEcCtD
Fenofibrate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000514	0.00113	CcSEcCtD
Fenofibrate—Malaise—Prednisone—ankylosing spondylitis	0.000511	0.00112	CcSEcCtD
Fenofibrate—Vertigo—Prednisone—ankylosing spondylitis	0.000509	0.00112	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—ankylosing spondylitis	0.000509	0.00111	CcSEcCtD
Fenofibrate—Anorexia—Betamethasone—ankylosing spondylitis	0.000506	0.00111	CcSEcCtD
Fenofibrate—Anorexia—Dexamethasone—ankylosing spondylitis	0.000506	0.00111	CcSEcCtD
Fenofibrate—Urticaria—Prednisolone—ankylosing spondylitis	0.000506	0.00111	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000505	0.00111	CcSEcCtD
Fenofibrate—Fatigue—Triamcinolone—ankylosing spondylitis	0.000505	0.00111	CcSEcCtD
Fenofibrate—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000504	0.0011	CcSEcCtD
Fenofibrate—Pain—Triamcinolone—ankylosing spondylitis	0.000501	0.0011	CcSEcCtD
Fenofibrate—Hypotension—Betamethasone—ankylosing spondylitis	0.000496	0.00109	CcSEcCtD
Fenofibrate—Hypotension—Dexamethasone—ankylosing spondylitis	0.000496	0.00109	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—ankylosing spondylitis	0.000494	0.00108	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000491	0.00107	CcSEcCtD
Fenofibrate—Hypertension—Prednisone—ankylosing spondylitis	0.000489	0.00107	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000484	0.00106	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000484	0.00106	CcSEcCtD
Fenofibrate—Arthralgia—Prednisone—ankylosing spondylitis	0.000483	0.00106	CcSEcCtD
Fenofibrate—Myalgia—Prednisone—ankylosing spondylitis	0.000483	0.00106	CcSEcCtD
Fenofibrate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000483	0.00106	CcSEcCtD
Fenofibrate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000481	0.00106	CcSEcCtD
Fenofibrate—Anxiety—Prednisone—ankylosing spondylitis	0.000481	0.00105	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—ankylosing spondylitis	0.000481	0.00105	CcSEcCtD
Fenofibrate—Insomnia—Betamethasone—ankylosing spondylitis	0.000481	0.00105	CcSEcCtD
Fenofibrate—Insomnia—Dexamethasone—ankylosing spondylitis	0.000481	0.00105	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000479	0.00105	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000478	0.00105	CcSEcCtD
Fenofibrate—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000477	0.00105	CcSEcCtD
Fenofibrate—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000477	0.00105	CcSEcCtD
Fenofibrate—Discomfort—Prednisone—ankylosing spondylitis	0.000477	0.00105	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—ankylosing spondylitis	0.000477	0.00104	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—ankylosing spondylitis	0.000474	0.00104	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—ankylosing spondylitis	0.000474	0.00104	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000469	0.00103	CcSEcCtD
Fenofibrate—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000468	0.00102	CcSEcCtD
Fenofibrate—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000468	0.00102	CcSEcCtD
Fenofibrate—Urticaria—Triamcinolone—ankylosing spondylitis	0.000465	0.00102	CcSEcCtD
Fenofibrate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000464	0.00102	CcSEcCtD
Fenofibrate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000463	0.00101	CcSEcCtD
Fenofibrate—Oedema—Prednisone—ankylosing spondylitis	0.000463	0.00101	CcSEcCtD
Fenofibrate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000462	0.00101	CcSEcCtD
Fenofibrate—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000462	0.00101	CcSEcCtD
Fenofibrate—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000462	0.00101	CcSEcCtD
Fenofibrate—Infection—Prednisone—ankylosing spondylitis	0.00046	0.00101	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000459	0.00101	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000459	0.00101	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—ankylosing spondylitis	0.000458	0.001	CcSEcCtD
Fenofibrate—Fatigue—Betamethasone—ankylosing spondylitis	0.000458	0.001	CcSEcCtD
Fenofibrate—Fatigue—Dexamethasone—ankylosing spondylitis	0.000458	0.001	CcSEcCtD
Fenofibrate—Pain—Betamethasone—ankylosing spondylitis	0.000454	0.000996	CcSEcCtD
Fenofibrate—Pain—Dexamethasone—ankylosing spondylitis	0.000454	0.000996	CcSEcCtD
Fenofibrate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000454	0.000994	CcSEcCtD
Fenofibrate—Tachycardia—Prednisone—ankylosing spondylitis	0.000452	0.00099	CcSEcCtD
Fenofibrate—Skin disorder—Prednisone—ankylosing spondylitis	0.000449	0.000985	CcSEcCtD
Fenofibrate—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000447	0.00098	CcSEcCtD
Fenofibrate—Anorexia—Prednisone—ankylosing spondylitis	0.000441	0.000967	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00044	0.000963	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—ankylosing spondylitis	0.000438	0.00096	CcSEcCtD
Fenofibrate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000438	0.000959	CcSEcCtD
Fenofibrate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000438	0.000959	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000434	0.000952	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000434	0.000952	CcSEcCtD
Fenofibrate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000431	0.000945	CcSEcCtD
Fenofibrate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00043	0.000943	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—ankylosing spondylitis	0.000427	0.000936	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—ankylosing spondylitis	0.000426	0.000933	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—ankylosing spondylitis	0.000424	0.000929	CcSEcCtD
Fenofibrate—Urticaria—Dexamethasone—ankylosing spondylitis	0.000422	0.000925	CcSEcCtD
Fenofibrate—Urticaria—Betamethasone—ankylosing spondylitis	0.000422	0.000925	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000422	0.000924	CcSEcCtD
Fenofibrate—Dizziness—Prednisolone—ankylosing spondylitis	0.000421	0.000923	CcSEcCtD
Fenofibrate—Asthenia—Triamcinolone—ankylosing spondylitis	0.00042	0.000921	CcSEcCtD
Fenofibrate—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00042	0.00092	CcSEcCtD
Fenofibrate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00042	0.00092	CcSEcCtD
Fenofibrate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00042	0.00092	CcSEcCtD
Fenofibrate—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00042	0.00092	CcSEcCtD
Fenofibrate—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000419	0.000919	CcSEcCtD
Fenofibrate—Insomnia—Prednisone—ankylosing spondylitis	0.000418	0.000917	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisone—ankylosing spondylitis	0.000415	0.00091	CcSEcCtD
Fenofibrate—Pruritus—Triamcinolone—ankylosing spondylitis	0.000414	0.000908	CcSEcCtD
Fenofibrate—Cough—Methotrexate—ankylosing spondylitis	0.000413	0.000906	CcSEcCtD
Fenofibrate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000413	0.000906	CcSEcCtD
Fenofibrate—Dyspepsia—Prednisone—ankylosing spondylitis	0.000407	0.000893	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—ankylosing spondylitis	0.000403	0.000884	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—ankylosing spondylitis	0.000403	0.000884	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—ankylosing spondylitis	0.000403	0.000884	CcSEcCtD
Fenofibrate—Decreased appetite—Prednisone—ankylosing spondylitis	0.000402	0.000881	CcSEcCtD
Fenofibrate—Rash—Prednisolone—ankylosing spondylitis	0.000401	0.00088	CcSEcCtD
Fenofibrate—Dermatitis—Prednisolone—ankylosing spondylitis	0.000401	0.000879	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000401	0.000878	CcSEcCtD
Fenofibrate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.0004	0.000876	CcSEcCtD
Fenofibrate—Fatigue—Prednisone—ankylosing spondylitis	0.000399	0.000874	CcSEcCtD
Fenofibrate—Headache—Prednisolone—ankylosing spondylitis	0.000399	0.000874	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—ankylosing spondylitis	0.000399	0.000873	CcSEcCtD
Fenofibrate—Constipation—Prednisone—ankylosing spondylitis	0.000396	0.000867	CcSEcCtD
Fenofibrate—Dizziness—Triamcinolone—ankylosing spondylitis	0.000387	0.000849	CcSEcCtD
Fenofibrate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000386	0.000847	CcSEcCtD
Fenofibrate—Infection—Methotrexate—ankylosing spondylitis	0.000384	0.000842	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000381	0.000836	CcSEcCtD
Fenofibrate—Asthenia—Dexamethasone—ankylosing spondylitis	0.000381	0.000835	CcSEcCtD
Fenofibrate—Asthenia—Betamethasone—ankylosing spondylitis	0.000381	0.000835	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000379	0.000831	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000379	0.00083	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000378	0.000829	CcSEcCtD
Fenofibrate—Nausea—Prednisolone—ankylosing spondylitis	0.000378	0.000829	CcSEcCtD
Fenofibrate—Pruritus—Dexamethasone—ankylosing spondylitis	0.000376	0.000824	CcSEcCtD
Fenofibrate—Pruritus—Betamethasone—ankylosing spondylitis	0.000376	0.000824	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—ankylosing spondylitis	0.000376	0.000823	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000374	0.000819	CcSEcCtD
Fenofibrate—Vomiting—Triamcinolone—ankylosing spondylitis	0.000372	0.000816	CcSEcCtD
Fenofibrate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000371	0.000814	CcSEcCtD
Fenofibrate—Rash—Triamcinolone—ankylosing spondylitis	0.000369	0.000809	CcSEcCtD
Fenofibrate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000369	0.000808	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—ankylosing spondylitis	0.000369	0.000808	CcSEcCtD
Fenofibrate—Rash—Methylprednisolone—ankylosing spondylitis	0.000368	0.000807	CcSEcCtD
Fenofibrate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000368	0.000807	CcSEcCtD
Fenofibrate—Urticaria—Prednisone—ankylosing spondylitis	0.000368	0.000806	CcSEcCtD
Fenofibrate—Headache—Triamcinolone—ankylosing spondylitis	0.000367	0.000804	CcSEcCtD
Fenofibrate—Headache—Methylprednisolone—ankylosing spondylitis	0.000366	0.000802	CcSEcCtD
Fenofibrate—Abdominal pain—Prednisone—ankylosing spondylitis	0.000366	0.000802	CcSEcCtD
Fenofibrate—Body temperature increased—Prednisone—ankylosing spondylitis	0.000366	0.000802	CcSEcCtD
Fenofibrate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000364	0.000797	CcSEcCtD
Fenofibrate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000364	0.000797	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—ankylosing spondylitis	0.000361	0.000792	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000352	0.000772	CcSEcCtD
Fenofibrate—Dizziness—Dexamethasone—ankylosing spondylitis	0.000351	0.00077	CcSEcCtD
Fenofibrate—Dizziness—Betamethasone—ankylosing spondylitis	0.000351	0.00077	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—ankylosing spondylitis	0.00035	0.000766	CcSEcCtD
Fenofibrate—Nausea—Triamcinolone—ankylosing spondylitis	0.000348	0.000762	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000347	0.000761	CcSEcCtD
Fenofibrate—Nausea—Methylprednisolone—ankylosing spondylitis	0.000347	0.000761	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000345	0.000755	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—ankylosing spondylitis	0.000344	0.000753	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000341	0.000747	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00034	0.000746	CcSEcCtD
Fenofibrate—Vomiting—Betamethasone—ankylosing spondylitis	0.000338	0.00074	CcSEcCtD
Fenofibrate—Vomiting—Dexamethasone—ankylosing spondylitis	0.000338	0.00074	CcSEcCtD
Fenofibrate—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000336	0.000737	CcSEcCtD
Fenofibrate—Rash—Betamethasone—ankylosing spondylitis	0.000335	0.000734	CcSEcCtD
Fenofibrate—Rash—Dexamethasone—ankylosing spondylitis	0.000335	0.000734	CcSEcCtD
Fenofibrate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000335	0.000733	CcSEcCtD
Fenofibrate—Dermatitis—Betamethasone—ankylosing spondylitis	0.000335	0.000733	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000334	0.000732	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—ankylosing spondylitis	0.000333	0.000731	CcSEcCtD
Fenofibrate—Headache—Dexamethasone—ankylosing spondylitis	0.000333	0.000729	CcSEcCtD
Fenofibrate—Headache—Betamethasone—ankylosing spondylitis	0.000333	0.000729	CcSEcCtD
Fenofibrate—Asthenia—Prednisone—ankylosing spondylitis	0.000332	0.000728	CcSEcCtD
Fenofibrate—Pain—Methotrexate—ankylosing spondylitis	0.000331	0.000725	CcSEcCtD
Fenofibrate—Pruritus—Prednisone—ankylosing spondylitis	0.000327	0.000717	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000319	0.000698	CcSEcCtD
Fenofibrate—Diarrhoea—Prednisone—ankylosing spondylitis	0.000317	0.000694	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000316	0.000693	CcSEcCtD
Fenofibrate—Nausea—Betamethasone—ankylosing spondylitis	0.000316	0.000692	CcSEcCtD
Fenofibrate—Nausea—Dexamethasone—ankylosing spondylitis	0.000316	0.000692	CcSEcCtD
Fenofibrate—Urticaria—Methotrexate—ankylosing spondylitis	0.000307	0.000673	CcSEcCtD
Fenofibrate—Dizziness—Prednisone—ankylosing spondylitis	0.000306	0.000671	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000306	0.00067	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000306	0.00067	CcSEcCtD
Fenofibrate—Vomiting—Prednisone—ankylosing spondylitis	0.000294	0.000645	CcSEcCtD
Fenofibrate—Rash—Prednisone—ankylosing spondylitis	0.000292	0.000639	CcSEcCtD
Fenofibrate—Dermatitis—Prednisone—ankylosing spondylitis	0.000291	0.000639	CcSEcCtD
Fenofibrate—Headache—Prednisone—ankylosing spondylitis	0.00029	0.000635	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000285	0.000624	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—ankylosing spondylitis	0.000277	0.000608	CcSEcCtD
Fenofibrate—Nausea—Prednisone—ankylosing spondylitis	0.000275	0.000602	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—ankylosing spondylitis	0.000274	0.0006	CcSEcCtD
Fenofibrate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000265	0.00058	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—ankylosing spondylitis	0.000256	0.00056	CcSEcCtD
Fenofibrate—Vomiting—Methotrexate—ankylosing spondylitis	0.000246	0.000539	CcSEcCtD
Fenofibrate—Rash—Methotrexate—ankylosing spondylitis	0.000244	0.000534	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—ankylosing spondylitis	0.000244	0.000534	CcSEcCtD
Fenofibrate—Headache—Methotrexate—ankylosing spondylitis	0.000242	0.000531	CcSEcCtD
Fenofibrate—Nausea—Methotrexate—ankylosing spondylitis	0.00023	0.000503	CcSEcCtD
